Garden State Investment Advisory Services LLC Bridge Bio Pharma, Inc. Transaction History
Garden State Investment Advisory Services LLC
- $363 Billion
- Q3 2024
A detailed history of Garden State Investment Advisory Services LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Garden State Investment Advisory Services LLC holds 11,588 shares of BBIO stock, worth $318,554. This represents 0.08% of its overall portfolio holdings.
Number of Shares
11,588
Previous 11,588
-0.0%
Holding current value
$318,554
Previous $294 Million
0.51%
% of portfolio
0.08%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
291Shares Held
171MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$694 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$691 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$390 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$342 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$167 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.08B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...